Quantification of von Willebrand Factor and von Willebrand Factor Propeptide in Patients with End Stage Renal Disease

被引：0
|
作者：
Davis, Rachael [1 ]
Bansal, Vinod [1 ]
Litinas, Evangelos [1 ]
Rahman, Saudur [1 ]
Hoppensteadt, Debra [1 ]
Conway, Brooke [2 ]
Fareed, Jawed [1 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] GTI Diagnost, Waukesha, WI USA
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] von Willebrand disease and quantitative variation in von Willebrand factor
    Mohlke, KL
    Ginsburg, D
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03): : 252 - 261
  • [22] Association of malaria severity with von Willebrand factor and von Willebrand factor propeptide levels and blood group.
    Donkor, C
    Hollestelle, MJ
    Akoto, AO
    O'Donnell, J
    van Mourik, JA
    Bunn, J
    BLOOD, 2003, 102 (11) : 71B - 71B
  • [23] Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
    Haberichter, Sandra L.
    Balistreri, Michael
    Christopherson, Pamela
    Morateck, Patricia
    Gavazova, Stefana
    Bellissimo, Daniel B.
    Manco-Johnson, Marilyn J.
    Gill, Joan Cox
    Montgomery, Robert R.
    BLOOD, 2006, 108 (10) : 3344 - 3351
  • [24] Phenotype IIC von Willebrand disease: In ''cis'' or in ''trans'' impact of propeptide mutations on von Willebrand factor multimerization?
    Gaucher, C
    Mazurier, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1490 - P1490
  • [25] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE
    MARAGALL, S
    CASTILLO, R
    ORDINAS, A
    LIENDO, F
    RODRIGUEZ, M
    THROMBOSIS RESEARCH, 1979, 14 (2-3) : 495 - 500
  • [26] VON-WILLEBRAND-FACTOR BINDING TO COLLAGEN IN PATIENTS WITH END-STAGE RENAL-DISEASE
    NIESVIZKY, R
    CALANDRI, C
    PATEL, ND
    ZHOU, SL
    POTTER, BJ
    RAND, JH
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (01): : 137 - 142
  • [27] Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome
    van Genderen, PJJ
    Boertjes, RC
    van Mourik, JA
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) : 495 - 498
  • [28] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [29] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    HAEMOPHILIA, 2021, 27 : 147 - 147
  • [30] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease
    Bukkems, Laura H.
    Heijdra, Jessica M.
    de Jager, Nico C. B.
    Hazendonk, Hendrika C. A. M.
    Fijnvandraat, Karin
    Meijer, Karina
    Eikenboom, Jeroen C. J.
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    BLOOD ADVANCES, 2021, 5 (05) : 1513 - 1522
12345